• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7135
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/11/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that shaft break occurred.The patient underwent percutaneous coronary intervention.The target lesion was located in a calcified right superficial femoral artery (sfa).A 3.50mm x 30mm emerge balloon catheter was advanced for dilatation.However, after the second inflation, the device broke in sfa.The device was retrieved using another guide.The procedure was completed successfully with no patient complications nor injuries reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an emerge mr balloon catheter.The device was visually and microscopically examined.There was blood and contrast present within the inflation lumen and balloon.The balloon was loosely folded.At 25mm distal to the midshaft bond, the inflation lumen was twisted and stretched for a length of 1mm.At 12mm distal from the rapid port exchange (rpe), the shaft was separated.Running distally from the rpe for a length of 12mm, there was a longitudinal tear of the inflation lumen and guidewire lumen.At the rpe for a length of 3mm, the shaft was stretched.
 
Event or Problem Description
It was reported that shaft break occurred.The patient underwent percutaneous coronary intervention.The target lesion was located in a calcified right superficial femoral artery (sfa).A 3.50mm x 30mm emerge balloon catheter was advanced for dilatation.However, after the second inflation, the device broke in sfa.The device was retrieved using another guide.The procedure was completed successfully with no patient complications nor injuries reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16513613
Report Number2124215-2023-10790
Device Sequence Number15012569
Product Code LOX
UDI-Device Identifier08714729806455
UDI-Public08714729806455
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K113220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/07/2024
Device Model Number7135
Device Catalogue Number7135
Device Lot Number0028361894
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/02/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/13/2023
Supplement Date Received by Manufacturer03/29/2023
Initial Report FDA Received Date03/09/2023
Supplement Report FDA Received Date04/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/10/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-